Meaningful Digital Biomarkers

Challenge: High Information Density

  • Histopathology images carry high information density.
  • To answer clinically relevant questions, meaningful quantitative biomarkers need to be extracted.
  • Predictive information can only be obtained from the complex interplay of different molecular mechanisms via robust algorithms.
     

Our Approach: Develop Meaningful Digital Biomarkers

  • Using advanced artificial intelligence (AI) technology, we derive novel digital biomarkers from tissue sections that capture previously hidden clinically relevant information.
  • Digital biomarkers characterizing tissue morphology can help make better use of routinely available tumor tissue to improve disease prognosis and understand disease mechanisms.
  • Digital biomarkers that characterize the immune contexture in the tumor microenvironment can help identify subgroups of patients who will benefit most from personalized therapies.
  • Through rigorous validation, we ensure that data-driven digital biomarkers are clinically meaningful.
  • Fraunhofer MEVIS has more than 10 years of experience in developing robust image analysis solutions that support pathologists in the assessment of biomarkers, reducing workload and simplifying workflows.

 

Research Topics

Automatic software for the data-driven discovery of image-based biomarkers based on foundation models. By leveraging outcome information, no manual annotations are required.
© Fraunhofer MEVIS
Software for the data-driven discovery of image-based biomarkers. Patient cohorts are analyzed automatically with respect to outcome or other patient-level labels.

Data-driven discovery of image-based biomarkers

  • Classical, knowledge-driven biomarker research is complemented by data-driven discovery of biomarkers to identify prognostic features from the combination of images and tabular clinical data.
  • We have implemented an identification of candidate biomarkers based on cell classes density features ranked by their potential for the predictive stratification [1].
  • Deep neural networks can identify complex patterns without using hand-crafted features and manual annotations, with foundation models serving as powerful feature extractors [2], [3].
  • Relevant corresponding image features can be discovered by analyzing the learned model using, e.g., explainability methods like attention weight visualization
     

References

[1] Data-Driven Discovery of Immune Contexture Biomarkers. Schwen et al. 2018. article

[2] Overcoming data scarcity in biomedical imaging with a foundational multi-task model. Schäfer et al. 2024. article

[3] Tissue concepts: Supervised foundation models in computational pathology. Nicke et al. 2025. article

 

Quantifying biomarkers relative to tumor boundaries allows characterizing the tumor microenvironment.
Cell densities depending on the distance to the tumor boundary. (https://doi.org/ggn3b2, CC BY)

Physiology-Based Quantification

  • Many image algorithms use square tiles for quantification, which does not reflect physiological structures.
  • Reflecting cellular properties depending on their location and interactions between neighboring cells, we
    • Compute biomarkers based on distances between cells [1],
    • Assess the tumor microenvironment by quantifying cell distances depending on the distance from the tumor boundary [1], and
    • Quantify tissue properties in biologically meaningful regions such as liver lobules [2, 3, 4].
       

References

[1] Data-Driven Discovery of Immune Contexture Biomarkers. Schwen et al. 2018. article

[2] Zonated quantification of steatosis in an entire mouse liver. Schwen et al. 2016. article

[3] Automated Detection of Portal Fields and Central Veins in Whole-Slide Images of Liver Tissue. Budelmann et al. 2022. article

[4] Joint zonated quantification of multiple parameters in hepatic lobules. Arp Laue et al. 2025. article

 

Fluorescence in-situ hybridization of ERBB2 amplification: automated signal counting for breast cancer assessment.
Amplification of the ERBB2 gene in breast tumor tissue visualized by fluorescence in-situ hybridization imaging. (https://doi.org/ghcp9g, CC BY-NC-ND)

Quantifying Chromosomal Aberrations with FISH

  • Specific chromosomal abnormalities like gene multiplications or translocations can be made visible with fluorescence in situ hybridization (FISH)
  • We have developed solutions for automated detection and quantification of such abormalities by
    • Segmenting cell nuclei in 4′,6-diamidino-2-phenylindole (DAPI)
    • Detecting FISH signals and analyzing their patterns within nuclei bounds
    • Quantifying FISH signals even for large gene multiplication counts (e.g., ERBB2)


References

[1] Automated density-based counting of FISH amplification signals for HER2 status assessment. Höfener et al. 2019. article

 

https://doi.org/jb5r (CC BY)

Representative Datasets

 

  • Digital biomarker studies are commonly based on non-representative datasets with narrowly defined patient collectives and strictly controlled environmental conditions
  • We explore digital biomarkers based on cancer registry data covering the full spectrum of routine clinical cases to uncover meaningful disease patterns [1].
  • We have extensive expertise in how to collect sufficient data and avoid bias so that datasets are truly representative [2].


References

 [1] Zusammenführung von Krebsregisterdaten und multimodalen, melderbasierten Diagnostikdaten zur KI-basierten Biomarker-Detektion. CanConnect

 [2] Recommendations on compiling test datasets for evaluating artificial intelligence solutions in pathology. Homeyer et al. 2022. article

 

Focused scoring based on hotspot analysis permits separating groups that are indiscernible by standard analysis
Focused scoring of steatosis separates groups. (https://doi.org/ggn3bv, CC BY)

Focused Scoring

  • Spatial heterogeneity of tissue can make quantitative assessment unreliable and a robust discrimination between different groups difficult.
  • Focused scoring is a hotspot analysis based on percentiles of scores obtained in a tile-based manner [1].
  • Focused scoring offers robustness with respect to imaging and detection artifacts and helps to reduce sample sizes for showing significant results.


Reference

[1] Focused scores enable reliable discrimination of small differences in steatosis, Homeyer et al 2018. article

 

Highly efficient algorithms enable automatic evaluation of lymphocytic infiltration of tumor regions in entire whole-slide images
© Fraunhofer MEVIS
Automated detection and evaluation of lymphocytes in breast tissue images.

Customized Solutions for Estabished Biomarkers

  • There are a large number of established histological biomarkers based on the quantification of cellular structures or the classification of morphological tissue patterns that benefit from computer support
  • We can leverage extensive expertise and software components to quickly develop customized new solutions for biomarker assessment [1, 2, 3]
  • We attach great importance to creating solutions that are both robust and efficient as well as easy to maintain and operate [4, 5]


References

[1] The NCI Imaging Data Commons as a platform for reproducible research in computational pathology. Schacherer et al. 2023. article

[2] Automated density-based counting of FISH amplification signals for HER2 status assessment. Höfener et al. 2019. article

[3] Deep learning nuclei detection: A simple approach can deliver state-of-the-art results.  Höfener et al. 2018. article

[4] Automated quantification of steatosis: agreement with stereological point counting. Homeyer et al. 2017. article

[5] Evaluation of the Transferability of a New “Learning” Histologic Image Analysis Application. Arlt et al. 2016. article

 

Contact

Contact Press / Media

Dr.-Ing. Henning Höfener

Principal Scientist Computational Pathology

Fraunhofer Institute for Digital Medicine MEVIS
Max-von-Laue-Str. 2
28359 Bremen

Phone +49 421 17879 2147

Contact Press / Media

Dr.-Ing. André Homeyer

Key Scientist Computational Pathology, Principal Data Scientist

Fraunhofer Institute for Digital Medicine MEVIS
Max-von-Laue-Str. 2
28359 Bremen

Phone +49 421 17879 2250

Contact Press / Media

Dr. rer. nat. Johannes Lotz

Principal Scientist Computational Pathology, Image Registration

Fraunhofer Institute for Digital Medicine MEVIS
Maria-Goeppert-Str. 3
23562 Lübeck

Phone +49 451 3101-6118

Fax +49 451 3101-6104

Contact Press / Media

Jan-Philip Redlich

Scientist Computational Pathology

Fraunhofer Institute for Digital Medicine MEVIS
Max-von-Laue-Str. 2
28359 Bremen

Phone +49 421 17879-2210

  • Send email

Contact Press / Media

Dr. rer. nat. Lars Ole Schwen

Senior Scientist Modeling and Simulation, Computational Pathology

Fraunhofer Institute for Digital Medicine MEVIS
Max-von-Laue-Str. 2
28359 Bremen

Phone +49 421 17879 2224

Contact Press / Media

Daniela Schacherer

Scientist Image Analysis

Fraunhofer Institute for Digital Medicine MEVIS
Max-von-Laue-Str. 2
28359 Bremen

Phone +49 421 17879 2218